Transition of Care in Type 1 Diabetes Mellitus
Improving Transition of Care in Type 1 Diabetes Mellitus: A Collaborative Approach
1 other identifier
observational
80
1 country
1
Brief Summary
This research project seeks to address the question of how to improve the transition of patients with type 1 diabetes mellitus from the paediatric to the adult health service at RNSH and Mona Vale Community Health Centre (seeking the perspectives of patients, families, and staff)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2023
CompletedFirst Submitted
Initial submission to the registry
June 21, 2023
CompletedFirst Posted
Study publicly available on registry
November 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2028
ExpectedNovember 2, 2023
October 1, 2023
1 year
June 21, 2023
October 30, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Patient self-efficacy (patient, family and staff member) relating to diabetes
From prospective questionnaires, with higher scores indicative of higher self-efficacy
From 9th June, 2023, ongoing for initial period of 5 years with interim sequential reviews
Diabetes knowledge questionnaire (patient and family member)
From prospective questionnaires, with a single correct answer per question
From 9th June, 2023, ongoing for initial period of 5 years with interim sequential reviews
Diabetes-related distress (patient and family member)
From prospective questionnaires, with higher scores indicative of higher distress levels
From 9th June, 2023, ongoing for initial period of 5 years with interim sequential reviews
Secondary Outcomes (3)
Patient medical outcomes
From 9th June, 2023, ongoing for initial period of up to 5 years with interim sequential reviews
Patient medical outcomes
From 9th June, 2023, ongoing for initial period of up to 5 years with interim sequential reviews
Patient medical outcomes
From 9th June, 2023, ongoing for initial period of up to 5 years with interim sequential reviews
Study Arms (2)
Retrospective cohort
Patients with type 1 diabetes mellitus known to Royal North Shore Hospital, who underwent transition from paediatric to adult health care from 1st January 2020-8th June 2023
Prospective cohort
Patients with type 1 diabetes mellitus known to Royal North Shore Hospital, undergoing transition from paediatric to adult health care, from 9th June 2023 onwards
Eligibility Criteria
Patients with type 1 diabetes mellitus meeting inclusion criteria, above
You may qualify if:
- Adolescents who have an existing diagnosis of type 1 diabetes mellitus and who underwent (in 2020 to 8th June, 2023) or who are undergoing (from 9th June, 2023 and subsequent cohorts) transition from paediatric care to adult health care at Royal North Shore Hospital and Mona Vale Community Health Centre. Adolescents with type 1 diabetes will be 16 years or older
- A family member or caregiver of the participant of the adolescent patient with type 1 diabetes mellitus
- A staff member who is a member of the patient's treating diabetes team within the paediatric diabetes service (first study visit and second study visit) and young adult diabetes service (third study visit)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal North Shore Hospital
Sydney, New South Wales, 2065, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shihab Hameed, MBBS
Royal North Shore Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 21, 2023
First Posted
November 2, 2023
Study Start
June 9, 2023
Primary Completion
June 9, 2024
Study Completion (Estimated)
June 9, 2028
Last Updated
November 2, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share